Stock Market News

Compass Pathways stock holds Buy rating on positive depression trial

Jun 24, 2025 - 12:54
 0
Compass Pathways stock holds Buy rating on positive depression trial
Read More

Tags:

Previous Article

Ocugen stock steady as H.C. Wainwright reiterates buy rating

Next Article

H.C. Wainwright maintains buy rating on Sana Biotechnology stock

Related Posts

Australia's Insignia Financial says Bain Capital pulls buyout bid, in talks with CC Capital

Australia's Insignia Financial says Bain Capital pulls ...

May 14, 2025  0

Dollar General lifts guidance after first-quarter sales top expectations

Dollar General lifts guidance after first-quarter sales...

Jun 3, 2025  0

BYD shares soar to record high; Citi hikes PT on export...

May 21, 2025  0